Hims & Hers Health, Inc. Chief Executive Officer and Director Andrew Dudum filed a Form 4 on November 17, 2026, disclosing RSU vesting and a related tax-withholding share disposition that occurred on November 13, 2026, on NYSE:HIMS.
Key Highlights
- RSU settlement: 154,990 shares of Class A Common Stock were acquired by Andrew Dudum on November 13, 2026, via conversion of restricted stock units (transaction code M).
- Tax withholding: 78,857 shares were disposed of at $19.73 per share on the same date to satisfy tax withholding obligations connected to the RSU vesting.
- Direct holdings after transactions: Dudum directly held 1,109,310 shares of Class A Common Stock following the reported transactions.
- Indirect holdings: An additional 7,199,015 shares are held indirectly across seven trusts, including the Dudum Family 2021 Trust (3,004,071 shares) and Dudum Family Heritage Trust UAD 8-10-2021 (2,214,769 shares).
- Remaining RSUs: Following the transactions, Dudum retained 35,447, 372,650, 172,354, and 336,249 RSUs outstanding across four separate RSU awards, all settling into Class A Common Stock.
- Four RSU grants involved: The vesting drew from grants with first vesting dates of June 15, 2023; June 15, 2024; June 15, 2025; and June 15, 2026, each on a 4-year quarterly schedule.
Dudum RSU Vesting Details and Share Disposition at Hims & Hers Health
According to the Form 4 filed with the SEC on November 17, 2026, Andrew Dudum, who serves as Chief Executive Officer, Director, and a reported 10% owner of Hims & Hers Health, Inc. (NYSE:HIMS), reported transactions dated November 13, 2026. The filing records the vesting and settlement of restricted stock units from four separate RSU grants, resulting in the acquisition of 154,990 shares of Class A Common Stock in total through transaction code M.
The filing discloses that 78,857 shares were simultaneously withheld by the issuer at $19.73 per share "to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs," as stated in the footnotes. After these two transactions, Dudum's direct beneficial ownership stood at 1,109,310 shares of Class A Common Stock. The four RSU grants each carry a service-based vesting requirement satisfied over a 4-year period in substantially equal quarterly installments on the company's quarterly vesting dates.
The filing also lists seven trusts through which Dudum holds shares indirectly, including the Andrew Dudum 2015 Trust Dated July 2, 2015 (573,202 shares), the AD 2025 GRAT dated 5-27-2025 (42,993 shares), the Dudum Family Community Property Trust (470,457 shares), the AD 2022 GRAT 2 dated 9/7/2022 (791,117 shares), the Dudum Legacy 2021 Trust (103,406 shares), the Dudum Family Heritage Trust UAD 8-10-2021 (2,214,769 shares), and the Dudum Family 2021 Trust (3,004,071 shares). The filing was signed by Kimberly Mather as attorney-in-fact for Andrew Dudum on November 17, 2026.
What Was Disclosed
This Form 4 discloses the vesting of 154,990 RSU-converted shares of Class A Common Stock and the withholding of 78,857 shares at $19.73 for tax purposes by Hims & Hers Health CEO Andrew Dudum on November 13, 2026, along with his updated direct and indirect beneficial ownership.



Please wait processing your request...